IL17A and Mycobacterium infection: Notably, there were no significant differences in the expression levels of IL-17 and IL-22 between the patient and control groups in this study, possibly due to the limited number of specimens, whereas previous studies reported that IL-17 and IL-22 acted to inhibit the progression of cutaneous Mycobacterium infections [23, 28].